As one of the most important annual events in the field of reproductive medicine, LensHooke once again participated in ESHRE 2026 (European Society of Human Reproduction and Embryology), joining reproductive medicine specialists, embryologists, clinicians, and researchers from around the world in London, United Kingdom, to exchange the latest research findings and clinical insights.

At this year's exhibition, LensHooke showcased a range of intelligent reproductive healthcare solutions, with the integrated application of the X12 Pro AI Semen Analysis System and the CA0 Sperm Selection Solution drawing significant attention. As the impact of sperm DNA Double-Strand Breaks (DSBs) on fertilization success, embryo quality, and pregnancy outcomes continues to gain recognition, improving the efficiency of selecting high-quality sperm has become a key topic of discussion among attendees.

At the LensHooke booth, visitors were invited to participate in a series of hands-on workshops, where they had the opportunity to experience the systems firsthand and explore their practical applications. The interactive sessions sparked engaging discussions on AI-assisted analysis, sperm quality assessment, and sperm selection technologies, highlighting the growing global interest in intelligent reproductive solutions.

The year 2026 also marks Bonraybio's 10th anniversary.

During the exhibition, LensHooke hosted a gala dinner with its global partners to celebrate a decade of collaboration in advancing reproductive medicine, express gratitude for their continued trust and support, and mark the beginning of the company's next chapter.

Let's look forward to what's next, together.